Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 6.45 Billion | USD 13.98 Billion | 8.1% | 2024 |
FrequentlyAsked Questions
Radiopharmaceuticals are a class of radioactive substances that can be utilized for therapeutic purpose or diagnostic purpose.
The global radiopharmaceutical market is expected to grow due to increasing demand for targeted cancer therapies, growing use of nuclear medicine in diagnostics, and advancements in radiotracers.
According to a study, the global radiopharmaceutical market size was worth around USD 6.45 Billion in 2024 and is expected to reach USD 13.98 Billion by 2034.
The global radiopharmaceutical market is expected to grow at a CAGR of 8.1% during the forecast period.
North America is expected to dominate the radiopharmaceutical market over the forecast period.
Leading players in the global radiopharmaceutical market include Jubilant Pharmova, Lantheus Holdings Inc., Mallinckrodt Pharmaceuticals, Cardinal Health Inc., GE Healthcare, Advanced Accelerator Applications, The Bracco Group, Eczacibasi-Monrol Nuclear Products, Nordion Inc., Bayer AG, IBA Molecular Imaging Private Limited, and Siemens Healthineers AG., among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed